In addition, Cu/Zn-SOD (SOD1) was indicated as a potential peripheral biomarker of oxidative damage in neurons and the level was significantly increased in HD patients compared to control, representing a compensatory response to increased oxidative levels in HD [83]. This evidence concerns the gene SOD1 and Huntington disease.